Osteoporosis R&D legislation
This article was originally published in The Tan Sheet
Executive Summary
Rep. Edward Markey (D-Mass.) introduces the Osteoporosis Risk Reduction Act of 1994 (HR 4284) on April 21 to require FDA to review the relationship between calcium intake and bone mass and osteoporosis. The bill would ask FDA to set optimum calcium intake levels, determine how many Americans consume too little calcium, and provide guidelines for fortifying of grain products with calcium
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning